VERTEX PHARMACEUTICALS INC / MA Share-based Payment Arrangement, Amount Capitalized
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Share-based Payment Arrangement, Amount Capitalized of $3.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Expensed and Capitalized, Amount
us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount · last filed 2026-08-04
- VERTEX PHARMACEUTICALS INC / MA share-based payment arrangement, amount capitalized for the quarter ending 2026-06-30 was $3.70M, a 5.13% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA share-based payment arrangement, amount capitalized for the quarter ending 2026-03-31 was $3.50M, a 20.69% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA share-based payment arrangement, amount capitalized for the quarter ending 2025-12-31 was $3.20M, a 3.23% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA share-based payment arrangement, amount capitalized for the quarter ending 2025-09-30 was $4.40M, a 22.22% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA share-based payment arrangement, amount capitalized for fiscal 2025 was $14.40M, a 35.85% increase from fiscal 2024.
- VERTEX PHARMACEUTICALS INC / MA share-based payment arrangement, amount capitalized for fiscal 2024 was $10.60M, a 360.87% increase from fiscal 2023.
- VERTEX PHARMACEUTICALS INC / MA share-based payment arrangement, amount capitalized for fiscal 2023 was $2.30M.
- VERTEX PHARMACEUTICALS INC / MA share-based payment arrangement, amount capitalized for fiscal 2022 was -$900.00K, a 121.95% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Amount Capitalized 3 month | Share-based Payment Arrangement, Amount Capitalized 3 month as first filed | Share-based Payment Arrangement, Amount Capitalized 6 month | Share-based Payment Arrangement, Amount Capitalized 6 month as first filed | Share-based Payment Arrangement, Amount Capitalized 9 month | Share-based Payment Arrangement, Amount Capitalized 9 month as first filed | Share-based Payment Arrangement, Amount Capitalized 12 month | Share-based Payment Arrangement, Amount Capitalized 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.70M 10-Q · filed 2026-08-04 | $7.20M 10-Q · filed 2026-08-04 | $10.40M derived: sum of 3 quarters · filed 2026-08-04 | $14.80M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $3.50M 10-Q · filed 2026-05-05 | $6.70M derived: sum of 2 quarters · filed 2026-05-05 | $11.10M derived: sum of 3 quarters · filed 2026-05-05 | $15.00M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $7.60M derived: sum of 2 quarters · filed 2026-02-13 | $11.50M derived: sum of 3 quarters · filed 2026-08-04 | $14.40M 10-K · filed 2026-02-13 | ||||
| 2025-09-30 | $4.40M 10-Q · filed 2025-11-04 | $8.30M derived: sum of 2 quarters · filed 2026-08-04 | $11.20M 10-Q · filed 2025-11-04 | $14.30M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $3.90M 10-Q · filed 2026-08-04 | $6.80M 10-Q · filed 2026-08-04 | $9.90M derived: sum of 3 quarters · filed 2026-08-04 | $13.50M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $2.90M 10-Q · filed 2026-05-05 | $6.00M derived: sum of 2 quarters · filed 2026-05-05 | $9.60M derived: sum of 3 quarters · filed 2026-05-05 | $12.40M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $6.70M derived: sum of 2 quarters · filed 2026-02-13 | $9.50M derived: sum of 3 quarters · filed 2026-02-13 | $10.60M 10-K · filed 2026-02-13 | ||||
| 2024-09-30 | $3.60M 10-Q · filed 2025-11-04 | $6.40M derived: sum of 2 quarters · filed 2025-11-04 | $7.50M 10-Q · filed 2025-11-04 | $8.00M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-06-30 | $2.80M 10-Q · filed 2025-08-05 | $3.90M 10-Q · filed 2025-08-05 | $4.40M derived: sum of 3 quarters · filed 2026-02-13 | $5.20M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-03-31 | $1.10M 10-Q · filed 2025-05-06 | $1.60M derived: sum of 2 quarters · filed 2026-02-13 | $2.40M derived: sum of 3 quarters · filed 2026-02-13 | $3.00M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2023-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $1.30M derived: sum of 2 quarters · filed 2026-02-13 | $1.90M derived: sum of 3 quarters · filed 2026-02-13 | $2.30M 10-K · filed 2026-02-13 | ||||
| 2023-09-30 | $800.00K 10-Q · filed 2024-11-05 | $1.40M derived: sum of 2 quarters · filed 2024-11-05 | $1.80M 10-Q · filed 2024-11-05 | $1.30M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-06-30 | $600.00K 10-Q · filed 2024-08-02 | $1.00M 10-Q · filed 2024-08-02 | $500.00K derived: sum of 3 quarters · filed 2025-02-13 | $200.00K derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-03-31 | $400.00K 10-Q · filed 2024-05-07 | -$100.00K derived: sum of 2 quarters · filed 2025-02-13 | -$400.00K derived: sum of 3 quarters · filed 2025-02-13 | -$700.00K derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2022-12-31 | -$500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | -$800.00K derived: sum of 2 quarters · filed 2025-02-13 | -$1.10M derived: sum of 3 quarters · filed 2025-02-13 | -$900.00K 10-K · filed 2025-02-13 | ||||
| 2022-09-30 | -$300.00K 10-Q · filed 2023-11-07 | -$600.00K derived: sum of 2 quarters · filed 2023-11-07 | -$400.00K 10-Q · filed 2023-11-07 | -$100.00K derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-06-30 | -$300.00K 10-Q · filed 2023-08-02 | -$100.00K 10-Q · filed 2023-08-02 | $200.00K derived: sum of 3 quarters · filed 2024-02-15 | $900.00K derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-03-31 | $200.00K 10-Q · filed 2023-05-02 | $500.00K derived: sum of 2 quarters · filed 2024-02-15 | $1.20M derived: sum of 3 quarters · filed 2024-02-15 | $2.50M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $1.00M derived: sum of 2 quarters · filed 2024-02-15 | $2.30M derived: sum of 3 quarters · filed 2024-02-15 | $4.10M 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | $700.00K 10-Q · filed 2022-10-28 | $658.00K 10-Q · filed 2021-11-03 | $2.00M derived: sum of 2 quarters · filed 2022-10-28 | $3.80M 10-Q · filed 2022-10-28 | $3.81M 10-Q · filed 2021-11-03 | $4.32M derived: sum of 4 quarters · filed 2023-02-10 | ||
| 2021-06-30 | $1.30M 10-Q · filed 2022-08-05 | $1.29M 10-Q · filed 2021-07-30 | $3.20M 10-Q · filed 2022-08-05 | $3.16M 10-Q · filed 2021-07-30 | $3.62M derived: sum of 3 quarters · filed 2023-02-10 | $4.57M derived: sum of 4 quarters · filed 2023-02-10 | ||
| 2021-03-31 | $1.80M 10-Q · filed 2022-05-06 | $1.86M 10-Q · filed 2021-04-30 | $2.32M derived: sum of 2 quarters · filed 2023-02-10 | $3.27M derived: sum of 3 quarters · filed 2023-02-10 | $4.21M derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2020-12-31 | $524.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $1.47M derived: sum of 2 quarters · filed 2023-02-10 | $2.41M derived: sum of 3 quarters · filed 2023-02-10 | $3.60M 10-K · filed 2023-02-10 | $3.61M 10-K · filed 2021-02-11 | |||
| 2020-09-30 | $950.00K 10-Q · filed 2021-11-03 | $1.88M derived: sum of 2 quarters · filed 2021-11-03 | $3.08M 10-Q · filed 2021-11-03 | $3.54M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-06-30 | $932.00K 10-Q · filed 2021-07-30 | $2.13M 10-Q · filed 2021-07-30 | $2.59M derived: sum of 3 quarters · filed 2022-02-09 | $3.13M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-03-31 | $1.19M 10-Q · filed 2021-04-30 | $1.66M derived: sum of 2 quarters · filed 2022-02-09 | $2.19M derived: sum of 3 quarters · filed 2022-02-09 | $2.44M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2019-12-31 | $464.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $1.00M derived: sum of 2 quarters · filed 2022-02-09 | $1.25M derived: sum of 3 quarters · filed 2022-02-09 | $1.70M 10-K · filed 2022-02-09 | $1.72M 10-K · filed 2020-02-13 | |||
| 2019-09-30 | $536.00K 10-Q · filed 2020-10-30 | $784.00K derived: sum of 2 quarters · filed 2020-10-30 | $1.24M 10-Q · filed 2020-10-30 | $1.37M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-06-30 | $248.00K 10-Q · filed 2020-07-31 | $700.00K 10-Q · filed 2020-07-31 | $831.00K derived: sum of 3 quarters · filed 2021-02-11 | $740.00K derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-03-31 | $452.00K 10-Q · filed 2020-05-01 | $583.00K derived: sum of 2 quarters · filed 2021-02-11 | $492.00K derived: sum of 3 quarters · filed 2021-02-11 | $572.00K derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2018-12-31 | $131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $40.00K derived: sum of 2 quarters · filed 2021-02-11 | $120.00K derived: sum of 3 quarters · filed 2021-02-11 | $585.00K 10-K · filed 2021-02-11 | ||||
| 2018-09-30 | -$91.00K 10-Q · filed 2019-10-31 | $91.00K 10-Q · filed 2018-10-25 | -$11.00K derived: sum of 2 quarters · filed 2019-10-31 | $454.00K 10-Q · filed 2019-10-31 | -$454.00K 10-Q · filed 2018-10-25 | $4.86M derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2018-06-30 | $80.00K 10-Q · filed 2019-08-01 | $545.00K 10-Q · filed 2019-08-01 | $4.95M derived: sum of 3 quarters · filed 2020-02-13 | $4.27M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-03-31 | $465.00K 10-Q · filed 2019-05-01 | $4.87M derived: sum of 2 quarters · filed 2020-02-13 | $4.19M derived: sum of 3 quarters · filed 2020-02-13 | $5.17M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | $4.41M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $3.73M derived: sum of 2 quarters · filed 2020-02-13 | $4.70M derived: sum of 3 quarters · filed 2020-02-13 | $2.41M 10-K · filed 2020-02-13 | $4.91M 10-K · filed 2018-02-15 | |||
| 2017-09-30 | -$678.00K 10-Q · filed 2018-10-25 | $1.36M 10-Q · filed 2017-10-30 | $294.00K derived: sum of 2 quarters · filed 2018-10-25 | -$2.00M 10-Q · filed 2018-10-25 | $3.66M 10-Q · filed 2017-10-30 | -$1.39M derived: sum of 4 quarters · filed 2019-02-13 | ||
| 2017-06-30 | $972.00K 10-Q · filed 2018-07-26 | $1.49M 10-Q · filed 2017-07-28 | $1.32M 10-Q · filed 2018-07-26 | $2.29M 10-Q · filed 2017-07-28 | -$716.00K derived: sum of 3 quarters · filed 2019-02-13 | $239.00K derived: sum of 4 quarters · filed 2019-02-13 | ||
| 2017-03-31 | $351.00K 10-Q · filed 2018-04-27 | $808.00K 10-Q · filed 2017-04-28 | -$1.69M derived: sum of 2 quarters · filed 2019-02-13 | -$733.00K derived: sum of 3 quarters · filed 2019-02-13 | $195.00K derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2016-12-31 | -$2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | -$1.08M derived: sum of 2 quarters · filed 2019-02-13 | -$156.00K derived: sum of 3 quarters · filed 2019-02-13 | $689.00K 10-K · filed 2019-02-13 | $3.61M 10-K · filed 2017-02-23 | |||
| 2016-09-30 | $955.00K 10-Q · filed 2017-10-30 | $1.88M derived: sum of 2 quarters · filed 2017-10-30 | $2.73M 10-Q · filed 2017-10-30 | $3.50M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-06-30 | $928.00K 10-Q · filed 2017-07-28 | $1.77M 10-Q · filed 2017-07-28 | $2.54M derived: sum of 3 quarters · filed 2018-02-15 | $3.82M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-03-31 | $845.00K 10-Q · filed 2017-04-28 | $1.61M derived: sum of 2 quarters · filed 2018-02-15 | $2.90M derived: sum of 3 quarters · filed 2018-02-15 | $4.05M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2015-12-31 | $769.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $2.05M derived: sum of 2 quarters · filed 2018-02-15 | $3.20M derived: sum of 3 quarters · filed 2018-02-15 | $4.09M 10-K · filed 2018-02-15 | ||||
| 2015-09-30 | $1.28M 10-Q · filed 2016-10-31 | $2.43M derived: sum of 2 quarters · filed 2016-10-31 | $3.32M 10-Q · filed 2016-10-31 | $3.84M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | $1.15M 10-Q · filed 2016-08-01 | $2.04M 10-Q · filed 2016-08-01 | $2.56M derived: sum of 3 quarters · filed 2017-02-23 | $3.01M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-03-31 | $884.00K 10-Q · filed 2016-05-03 | $1.40M derived: sum of 2 quarters · filed 2017-02-23 | $1.86M derived: sum of 3 quarters · filed 2017-02-23 | $2.10M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | $518.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $974.00K derived: sum of 2 quarters · filed 2017-02-23 | $1.22M derived: sum of 3 quarters · filed 2017-02-23 | $1.42M 10-K · filed 2017-02-23 | ||||
| 2014-09-30 | $456.00K 10-Q · filed 2015-10-30 | $698.00K derived: sum of 2 quarters · filed 2015-10-30 | $905.00K 10-Q · filed 2015-10-30 | $1.07M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-06-30 | $242.00K 10-Q · filed 2015-08-04 | $449.00K 10-Q · filed 2015-08-04 | $612.00K derived: sum of 3 quarters · filed 2016-02-16 | $816.00K derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-03-31 | $207.00K 10-Q · filed 2015-05-04 | $370.00K derived: sum of 2 quarters · filed 2016-02-16 | $574.00K derived: sum of 3 quarters · filed 2016-02-16 | $956.00K derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2013-12-31 | $163.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-16 | $367.00K derived: sum of 2 quarters · filed 2016-02-16 | $749.00K derived: sum of 3 quarters · filed 2016-02-16 | $1.05M 10-K · filed 2016-02-16 | ||||
| 2013-09-30 | $204.00K 10-Q · filed 2014-11-06 | $586.00K derived: sum of 2 quarters · filed 2014-11-06 | $885.00K 10-Q · filed 2014-11-06 | $1.25M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-06-30 | $382.00K 10-Q · filed 2014-07-31 | $681.00K 10-Q · filed 2014-07-31 | $1.05M derived: sum of 3 quarters · filed 2015-02-13 | $1.39M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-03-31 | $299.00K 10-Q · filed 2014-05-05 | $665.00K derived: sum of 2 quarters · filed 2015-02-13 | $1.00M derived: sum of 3 quarters · filed 2015-02-13 | $1.30M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2012-12-31 | $366.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $705.00K derived: sum of 2 quarters · filed 2015-02-13 | $1.00M derived: sum of 3 quarters · filed 2015-02-13 | $1.25M 10-K · filed 2015-02-13 | ||||
| 2012-09-30 | $339.00K 10-Q · filed 2013-11-07 | -$339.00K 10-Q · filed 2012-11-06 | $638.00K derived: sum of 2 quarters · filed 2013-11-07 | $888.00K 10-Q · filed 2013-11-07 | -$888.00K 10-Q · filed 2012-11-06 | $2.76M derived: sum of 4 quarters · filed 2014-02-11 | ||
| 2012-06-30 | $299.00K 10-Q · filed 2013-08-02 | -$299.00K 10-Q · filed 2012-08-08 | $549.00K 10-Q · filed 2013-08-02 | -$549.00K 10-Q · filed 2012-08-08 | $2.42M derived: sum of 3 quarters · filed 2014-02-11 | $2.13M derived: sum of 4 quarters · filed 2014-02-11 | ||
| 2012-03-31 | $250.00K 10-Q · filed 2013-05-08 | -$250.00K 10-Q · filed 2012-05-10 | $2.12M derived: sum of 2 quarters · filed 2014-02-11 | $1.83M derived: sum of 3 quarters · filed 2014-02-11 | $1.45M derived: sum of 4 quarters · filed 2014-02-11 | |||
| 2011-12-31 | $1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-11 | $1.58M derived: sum of 2 quarters · filed 2014-02-11 | $1.20M derived: sum of 3 quarters · filed 2014-02-11 | $1.04M 10-K · filed 2014-02-11 | -$1.04M 10-K · filed 2012-02-22 | |||
| 2011-09-30 | -$294.00K 10-Q · filed 2012-11-06 | -$676.00K derived: sum of 2 quarters · filed 2012-11-06 | -$830.00K 10-Q · filed 2012-11-06 | |||||
| 2011-06-30 | -$382.00K 10-Q · filed 2012-08-08 | -$536.00K 10-Q · filed 2012-08-08 | ||||||
| 2011-03-31 | -$154.00K 10-Q · filed 2012-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |